Crossmark

Era of surrogate endpoints and accelerated approvals: a comprehensive review on applicability, uncertainties, and challenges from regulatory, payer, and patient perspectives

Crossref DOI link: https://doi.org/10.1007/s00228-025-03822-w

Published Online: 2025-03-13

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sharma, Rohini

Gulati, Anamika

Chopra, Kanwaljit
License Information

Text and Data Mining valid from 2025-03-13

Version of Record valid from 2025-03-13
More Information

Article History

Received: 31 January 2025

Accepted: 3 March 2025

First Online: 13 March 2025

Declarations

:

: During the preparation of this work, the authors used AI-assisted technology (ChatGPT 4.0) in order to improve the readability and language of the work at places. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.

Document is current

Any future updates will be listed below